2x Blend (CJC-1295 No DAC + Ipamorelin)

$99.00

You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process

A powerful peptide blend combining CJC-1295 (No DAC) and Ipamorelin, designed for research on growth hormone stimulation and pituitary gland activation. Supplied as a lyophilized powder for maximum purity and stability.
2x Blend (CJC-1295 No DAC + Ipamorelin)
2x Blend (CJC-1295 No DAC + Ipamorelin) - Image 2

Aion Aminos

Precision Peptides for Advanced Research

This dual-compound peptide formulation combines CJC-1295 (No DAC) with Ipamorelin, a selective ghrelin receptor agonist studied in endocrine signaling research. The blend is frequently examined in laboratory environments to investigate how these peptides interact with pathways associated with growth hormone signaling and pituitary gland activation. CJC-1295 No DAC is a modified analog of growth hormone releasing hormone (GHRH) studied for its interaction with receptors in the pituitary gland responsible for growth hormone signaling. Ipamorelin is a synthetic peptide that activates the ghrelin receptor pathway and is commonly used in research exploring growth hormone signaling networks and endocrine communication. When studied together, researchers often evaluate the combined activity of these compounds to investigate potential synergistic signaling pathways related to growth hormone production, receptor activation, and endocrine regulatory processes involved in cellular growth and metabolic signaling. This compound blend is supplied as a stable, research-grade lyophilized powder designed for controlled laboratory investigation.

Research Applications (Laboratory Use Only)

In laboratory environments, CJC-1295 (No DAC) + Ipamorelin is commonly studied to investigate endocrine signaling pathways related to growth hormone regulation. Researchers frequently analyze how activation of receptors in the pituitary gland influences growth hormone production and downstream molecular signaling networks.

Experimental studies often examine interactions between growth hormone releasing hormone analogs and ghrelin receptor agonists to evaluate their influence on receptor activity and cellular communication within endocrine systems. These investigations frequently focus on signaling pathways associated with cellular growth, hormone regulation, and metabolic communication.

Scientific literature also explores how these peptides interact with regulatory networks affecting hormone-mediated signaling within endocrine tissues. Research models often analyze receptor-mediated communication pathways involved in endocrine regulation and cellular adaptation to hormonal signaling.

All such investigations remain confined strictly to laboratory research contexts and do not represent approved medical or therapeutic applications.

Key Features

  • Dual peptide blend containing CJC-1295 (No DAC) and Ipamorelin

  • Classified as a research-grade endocrine signaling compound

  • CJC-1295 No DAC is a modified analog of growth hormone releasing hormone

  • Ipamorelin functions as a selective ghrelin receptor agonist in research models

  • Studied in laboratory environments for growth hormone signaling pathways

  • Investigated in experimental systems examining pituitary gland receptor activity

  • Explored in endocrine research involving growth hormone production and receptor-mediated signaling

  • Research literature examines growth hormone pathways related to cellular growth and metabolic signaling

  • Supplied as lyophilized powder for laboratory handling and stability

  • Packaged in sterile vial format for research use

  • Distributed for laboratory research within the United States

Not intended for therapeutic use or human consumption

Frequently Asked Questions

This product is a dual-peptide blend combining CJC-1295 No DAC, a modified growth hormone releasing hormone analog, and Ipamorelin, a ghrelin receptor agonist studied in endocrine signaling research.

Researchers often study this peptide combination in laboratory models investigating growth hormone signaling, pituitary gland receptor activation, and endocrine communication pathways.

Scientific research sometimes evaluates how combining CJC-1295 and Ipamorelin may influence receptor activity and hormone-related signaling pathways within endocrine systems.

No. This peptide blend is supplied strictly for research use and is not intended for human consumption, supplementation, or therapeutic use.

More Peptides

Related products

  • our customers love us
  • our customers love us
Aion Aminos